(Q37172003)

English

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

scientific article published on 15 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis (English)

1 reference

Europe PubMed Central

18 August 2017

1 reference

based on heuristic

inferred from title

Angela Dispenzieri

2

object named as

Angela Dispenzieri

1 reference

Europe PubMed Central

18 August 2017

10

object named as

Robert A Kyle

1 reference

Europe PubMed Central

18 August 2017

3

object named as

Martha Q Lacy

1 reference

Europe PubMed Central

18 August 2017

S. Vincent Rajkumar

11

object named as

S Vincent Rajkumar

1 reference

Europe PubMed Central

18 August 2017

12

object named as

Morie A Gertz

1 reference

Europe PubMed Central

18 August 2017

Suzanne R Hayman

4

object named as

Suzanne R Hayman

1 reference

Europe PubMed Central

18 August 2017

Steven R Zeldenrust

6

object named as

Steven R Zeldenrust

1 reference

Europe PubMed Central

18 August 2017

Francis K Buadi

5

object named as

Francis K Buadi

1 reference

Europe PubMed Central

18 August 2017

1

object named as

Shaji K Kumar

1 reference

Europe PubMed Central

18 August 2017

Shirshendu Sinha

8

object named as

Shirshendu Sinha

1 reference

Europe PubMed Central

18 August 2017

author name string

Tow Tan

7

1 reference

Europe PubMed Central

18 August 2017

Nelson Leung

9

1 reference

Europe PubMed Central

18 August 2017

publication date

15 February 2011

1 reference

Europe PubMed Central

18 August 2017

American Journal of Hematology

1 reference

Europe PubMed Central

18 August 2017

86

1 reference

Europe PubMed Central

18 August 2017

3

1 reference

Europe PubMed Central

18 August 2017

251-255

1 reference

Europe PubMed Central

18 August 2017

Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

International uniform response criteria for multiple myeloma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Amyloidosis: diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

"Primary" systemic amyloidosis and myeloma. Discussion of relationship and review of 81 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Stem cell transplantation for the management of primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

6 September 2017

Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3773466

3 September 2018

Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.21948

21 January 2018

Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response

1 reference

https://pubmed.ncbi.nlm.nih.gov/21328431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/21328431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response rates and survival in primary systemic amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21328431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJH.21948

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37172003&oldid=2158841051"